Home » Glenmark Pharma Gains as Anti-Diarrheal Drug Enters Pivotal Trials
Glenmark Pharma Gains as Anti-Diarrheal Drug Enters Pivotal Trials
Glenmark Pharmaceuticals shares rose after the company said it has obtained the DCGI (India) approval for conduct of the pivotal study of Crofelemer in acute watery diarrhea patients.
IndiaInfoLine
IndiaInfoLine
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May